CoChat

The Role of Sumoylation in the Response to Hypoxia: An Overview

Open access

The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.

Abstract

Sumoylation is the covalent attachment of the small ubiquitin-related modifier (SUMO) to a vast variety of proteins in order to modulate their function. Sumoylation has emerged as an important modification with a regulatory role in the cellular response to different types of stress including osmotic, hypoxic and oxidative stress. Hypoxia can occur under physiological or pathological conditions, such as ischemia and cancer, as a result of an oxygen imbalance caused by low supply and/or increased consumption. The hypoxia inducible factors (HIFs), and the proteins that regulate their fate, are critical molecular mediators of the response to hypoxia and modulate procedures such as glucose and lipid metabolism, angiogenesis, erythropoiesis and, in the case of cancer, tumor progression and metastasis. Here, we provide an overview of the sumoylation-dependent mechanisms that are activated under hypoxia and the way they influence key players of the hypoxic response pathway. As hypoxia is a hallmark of many diseases, understanding the interrelated connections between the SUMO and the hypoxic signaling pathways can open the way for future molecular therapeutic interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells9112359

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The SUMO conjugation mechanism. Initially the SUMO precursor form is proteolytically cleaved (by SUMO-specific proteases) to expose the C-terminal glycine–glycine (GG) motif. Mature SUMO is activated by the SUMO E1 heterodimer SAE1/SAE2 (Aos1/Uba2) in an ATP-dependent manner, then a thioester bond is formed between the C-terminal glycine of SUMO and the catalytic cysteine (-SH) of SAE2. SUMO is subsequently loaded to the catalytic cysteine of the SUMO E2 enzyme Ubc9. Ubc9 catalyzes formation of an isopeptide bond between the C-terminal glycine of SUMO and a lysine residue in the substrate. This procedure is usually facilitated by a SUMO E3 ligase. Sumoylation can occur as mono-sumoylation, poly-mono-sumoylation or polysumoylation (formation of sumo chains) on target substrates. Sumoylation is reversed by SUMO-specific proteases that cleave the isopeptide bond and release SUMO.
Figure 1 The SUMO conjugation mechanism. Initially the SUMO precursor form is proteolytically cleaved (by SUMO-specific proteases) to expose the C-terminal glycine–glycine (GG) motif. Mature SUMO is activated by the SUMO E1 heterodimer SAE1/SAE2 (Aos1/Uba2) in an ATP-dependent manner, then a thioester bond is formed between the C-terminal glycine of SUMO and the catalytic cysteine (-SH) of SAE2. SUMO is subsequently loaded to the catalytic cysteine of the SUMO E2 enzyme Ubc9. Ubc9 catalyzes formation of an isopeptide bond between the C-terminal glycine of SUMO and a lysine residue in the substrate. This procedure is usually facilitated by a SUMO E3 ligase. Sumoylation can occur as mono-sumoylation, poly-mono-sumoylation or polysumoylation (formation of sumo chains) on target substrates. Sumoylation is reversed by SUMO-specific proteases that cleave the isopeptide bond and release SUMO.CC BY · PubMed Central
Figure 2 The hypoxic signaling pathway. The hypoxic signaling pathway: Under normoxia HIFα is hydroxylated by PHD and FIH hydroxylases in an oxygen dependent manner. Hydroxylation by PHD leads to pVHL and E3 ubiquitin ligase recruitment, ubiquitination of HIFα and subsequent proteasomal degradation. Hydroxylation by FIH leads to transcriptional inactivation. Low O2 inactivates both PHD and FIH hydroxylases, HIFα is stabilized, enters the nucleus, dimerizes with HIF-1β (ARNT), binds to specific DNA elements (hypoxia responsive elements) and, in association with transcription coactivators such as CBP/p300, stimulates the transcription of hypoxia target genes.
Figure 2 The hypoxic signaling pathway. The hypoxic signaling pathway: Under normoxia HIFα is hydroxylated by PHD and FIH hydroxylases in an oxygen dependent manner. Hydroxylation by PHD leads to pVHL and E3 ubiquitin ligase recruitment, ubiquitination of HIFα and subsequent proteasomal degradation. Hydroxylation by FIH leads to transcriptional inactivation. Low O2 inactivates both PHD and FIH hydroxylases, HIFα is stabilized, enters the nucleus, dimerizes with HIF-1β (ARNT), binds to specific DNA elements (hypoxia responsive elements) and, in association with transcription coactivators such as CBP/p300, stimulates the transcription of hypoxia target genes.CC BY · PubMed Central
Figure 3 Schematic representation of the association of hypoxic signaling agents with SUMO and its effect on hypoxia inducible factor (HIF) stability and activity. (A) HIFα sumoylation affects its transcriptional activity. E3 ligases PIAS3, Cbx4 and RSUME may mediate sumoylation and activation of HIF-1, while HIF-1α sumoylation by E3 ligase PIASy may lead to its proteasomal degradation. Desumoylation of HIF-1α by sumo isopeptidase SENP1 may lead to stabilization. HIF-2α sumo modification leads to VHL and RNF4 dependent ubiquitination and proteasomal degradation. (B) Sumoylation of HIFα hydroxylases affects their activity. Modification of PHD3 causes inhibition of HIF-1 transcriptional activity, without, however, affecting HIF-1α protein stability. Sumoylation of FIH promotes its proteasomal degradation, thus enhancing the transcriptional activity of HIF-1α. (C) Sumoylation of p300 and CBP affects HIF-1 activity. SUMO conjugation of p300 or CBP leads to transcriptional repression of HIF-1 target genes mediated by SUMO-dependent recruitment of HDAC6 and HDAC2/DAXX, respectively. (D) Sumoylation of pVHL by PIASy promotes its deactivation leading to HIF stabilization and activation. Relevant references and details can be found in Table 1.
Figure 3 Schematic representation of the association of hypoxic signaling agents with SUMO and its effect on hypoxia inducible factor (HIF) stability and activity. (A) HIFα sumoylation affects its transcriptional activity. E3 ligases PIAS3, Cbx4 and RSUME may mediate sumoylation and activation of HIF-1, while HIF-1α sumoylation by E3 ligase PIASy may lead to its proteasomal degradation. Desumoylation of HIF-1α by sumo isopeptidase SENP1 may lead to stabilization. HIF-2α sumo modification leads to VHL and RNF4 dependent ubiquitination and proteasomal degradation. (B) Sumoylation of HIFα hydroxylases affects their activity. Modification of PHD3 causes inhibition of HIF-1 transcriptional activity, without, however, affecting HIF-1α protein stability. Sumoylation of FIH promotes its proteasomal degradation, thus enhancing the transcriptional activity of HIF-1α. (C) Sumoylation of p300 and CBP affects HIF-1 activity. SUMO conjugation of p300 or CBP leads to transcriptional repression of HIF-1 target genes mediated by SUMO-dependent recruitment of HDAC6 and HDAC2/DAXX, respectively. (D) Sumoylation of pVHL by PIASy promotes its deactivation leading to HIF stabilization and activation. Relevant references and details can be found in Table 1.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 153 references

Research works printed but not linked: 2

  1. Wilson, V.G. (2019). SUMOylation and Ubiquitination: Current and Emerging Concepts, Caister Academic Press Limited.
  2. Steinhoff, A., Kaiser, F., and Depping, R. (July, January 28). SUMOylation of HIF-1alpha and HIF-2alpha: PP3-77. Proceedings of the 33rd FEBS Congress & 11th IUBMB Conference, Athens, Greece.

Cited by

See all 66

Metadata

Authors
Filippopoulou, C., Simos, G., & Chachami, G.
Affiliations
University of Thessaly (GR)
Corresponding author
Chachami, Georgia
Venue
Cells
Publisher
MDPI AG
Published
2020-10-26
Volume
9
Issue
11
Pages
2359
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3096288868
Cited by
56
References
152
Citations by year
2026: 9 · 2025: 12 · 2024: 5 · 2023: 7 · 2022: 11 · 2021: 10 · 2020: 1
FWCI
0.69
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
Funders
Hellenic Foundation for Research and Innovation (1460)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
SUMOylation, SUMO, hypoxia, hypoxia-inducible factor, post-translational modification, ischemia, cancer, tumor progression, metastasis, angiogenesis, erythropoiesis, glycolipid metabolism, oxidative stress, osmotic stress
MeSH terms
Animals, Humans, Models, Biological, Stress, Physiological, Signal Transduction, Cell Hypoxia, Small Ubiquitin-Related Modifier Proteins, Sumoylation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Sumoylation in the Response to Hypoxia: An Overview. https://app.cochat.ai/papers/10.3390/cells9112359
The paper
Filippopoulou, C., Simos, G., & Chachami, G. (2020). The Role of Sumoylation in the Response to Hypoxia: An Overview. Cells. https://doi.org/10.3390/cells9112359

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.